Hypoxia and calcium ions exhibited enhanced immunomodulatory functions of MSCs used to treat GVHD via the monocyte chemoattractant protein-1 (MCP-1) and p53/p21 cascade [28]. Here, CCL2 is linked to graft versus host disease.